These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 37755974)

  • 1. Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies.
    Mitrea L; Medeleanu M; Pop CR; Rotar AM; Vodnar DC
    Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.
    Ondrussek-Sekac M; Navas-Carrillo D; Orenes-Piñero E
    Crit Rev Food Sci Nutr; 2021; 61(9):1490-1502. PubMed ID: 32393049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Microbiome and Uremic Solutes.
    Zaidan N; Nazzal L
    Toxins (Basel); 2022 Mar; 14(4):. PubMed ID: 35448854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota Transplantation in Reducing Uremic Toxins Accumulation in Kidney Disease: Current Understanding and Future Perspectives.
    Caggiano G; Stasi A; Franzin R; Fiorentino M; Cimmarusti MT; Deleonardis A; Palieri R; Pontrelli P; Gesualdo L
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
    Hsu CN; Tain YL
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate.
    Młynarska E; Budny E; Saar M; Wojtanowska E; Jankowska J; Marciszuk S; Mazur M; Rysz J; Franczyk B
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the Importance of Biotics in Gut Barrier Integrity.
    Kocot AM; Jarocka-Cyrta E; Drabińska N
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Pre- and Probiotics to Post-Biotics: A Narrative Review.
    Scarpellini E; Rinninella E; Basilico M; Colomier E; Rasetti C; Larussa T; Santori P; Abenavoli L
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective.
    Lohia S; Vlahou A; Zoidakis J
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota and prebiotics modulation of uremic toxin generation.
    Koppe L; Fouque D
    Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
    Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
    Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE.
    Dobrek Ł
    Wiad Lek; 2022; 75(7):1757-1764. PubMed ID: 35962694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
    Vitetta L; Linnane AW; Gobe GC
    Toxins (Basel); 2013 Nov; 5(11):2042-57. PubMed ID: 24212182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease.
    Mafra D; Borges N; Alvarenga L; Esgalhado M; Cardozo L; Lindholm B; Stenvinkel P
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.